The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes ...

The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...

USA: A study published in Diabetes Care found that the rate of diabetic ketoacidosis (DKA) at the time of type 1 diabetes ...

The Federal Trade Commission is pressing pause on its legal fight with major pharmacy benefit managers. | The agency ...

A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings. The former chair is not pleased.

Inhaled insulin has been available for about a decade, offering a rapid-acting alternative to traditional insulin shots.

Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with ...

Experts aren’t really on board with taking these new, buzzy, multi-ingredient supplements that claim to help with insulin ...

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

Cross-sectional studies and Mendelian randomization show that insulin resistance and chronic inflammation mediate the ...

The publication, entitled “Advance Insulin Injection Technique and Education with FITTER Forward Expert Recommendations,” is available in Mayo Clinic Proceedings ’ April print edition and online here ...

The measure would allow direct-support professionals or relatives to administer the shot in an facility licensed by the state Agency for Persons With Disabilities. Currently, only nurses can do so.